Stockpolly
Search
DERM · NASDAQ · Drug Manufacturers - Specialty & Generic

Journey Medical (DERM)

Markets prescription dermatology medicines through a focused U.S. sales organization.

$7.85
Pre-market+0.07 (+0.90%)
At close$7.78(+2.77%)
Watchlist

Something off on this page? Send us feedback.

Breakdown13F · 13D/G · Form 4

Institutions74 holders · as of Jun 30, 202637.95%10.71M shares
Insiders9 holders · as of Jul 2, 202618.04%5.09M shares
Strategic holders1 holder · as of May 31, 202434.94%9.86M shares
Otherremainder9.07%2.56M shares

28.22M company shares as of Sep 3, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

This company has 2 share classes; every stake here is a share of the whole company.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesEvidence
Fortress Biotech, Inc.1Strategic10 percent owner
34.94%10.01M13Gfiled May 31, 2024 ↗
Wasatch Advisors LPInstitution
10.13%2.86M13Fas of Jun 30, 2026
Claude MaraouiInsiderdirector, officer: President & CEO
8.63%2.44MForm 4filed Apr 24, 2026 ↗
Tang Capital Management LLCInstitution
5.70%1.61M13Fas of Jun 30, 2026
Bryant R. RileyInsider
3.33%939,69513Gfiled Feb 11, 2022 ↗
Vanguard Capital Management LLCInstitution
2.39%675,18513Fas of Jun 30, 2026
Ramsey AlloushInsiderofficer: Chief Operating Officer
2.12%598,543Form 4filed Apr 24, 2026 ↗
Punch & Associates Investment Management, Inc.Institution
1.90%536,00013Fas of Jun 30, 2026
Pale Fire Capital SEInstitution
1.87%528,58413Fas of Jun 30, 2026
Opaleye Management Inc.Institution
1.24%350,00013Fas of Jun 30, 2026
Summit Financial, LLCInstitution
1.23%346,74813Fas of Jun 30, 2026
Jane Street Group, LLCInstitution
1.13%320,02113Fas of Jun 30, 2026
Diametric Capital, LPInstitution
1.05%295,66313Fas of Jun 30, 2026
Joseph BeneschInsiderofficer: CFO
0.93%261,371Form 4filed Apr 24, 2026 ↗
Ikarian Capital, LLCInstitution
0.89%251,43613Fas of Jun 30, 2026
Justin Adam SmithInsiderdirector
0.82%231,618Form 4filed Jul 2, 2026 ↗
Renaissance Technologies LLCInstitution
0.81%229,70013Fas of Jun 30, 2026
Lindsay A. Md RosenwaldInsiderdirector
0.78%221,146Form 4filed Jun 26, 2026 ↗
Geode Capital Management, LLCInstitution
0.77%216,00413Fas of Jun 30, 2026
American Financial Group IncInstitution
0.64%180,00013Fas of Jun 30, 2026
Trexquant Investment LPInstitution
0.61%171,33813Fas of Jun 30, 2026
Neil HerskowitzInsiderdirector
0.60%168,618Form 4filed Jul 2, 2026 ↗
Miranda Jayne ToledanoInsiderdirector
0.60%168,618Form 4filed Jul 2, 2026 ↗
Marshall Wace, LLPInstitution
0.50%139,84313Fas of Jun 30, 2026
J. Goldman & Co LPInstitution
0.49%137,58413Fas of Jun 30, 2026
  1. Fortress Biotech, Inc.'s transaction reports restate only vehicles that traded; the 2022 ownership statement (10.01M) less the 150.0K net shares sold since is used instead.

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F, as of Jun 30, 2026

74 holders · 10.71M shares · 24 new positions · 44 increased · 23 reduced · 24 closed

HolderShares% of companyChg q/qFiled
Wasatch Advisors LP2.86M10.13%+725.6KJul 10, 2026
Tang Capital Management LLC1.61M5.70%0Aug 14, 2026
Vanguard Capital Management LLC675.2K2.39%−406.9KAug 13, 2026
Punch & Associates Investment Management, Inc.536.0K1.90%+536.0KnewAug 14, 2026
Pale Fire Capital SE528.6K1.87%+46.6KAug 13, 2026
Opaleye Management Inc.350.0K1.24%−610.0KAug 14, 2026
Summit Financial, LLC346.7K1.23%−33.1KAug 12, 2026
Jane Street Group, LLC320.0K1.13%+320.0KAug 14, 2026

Ownership statements13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Wasatch Advisors LP13.30%2.86M13GJul 15, 2026 ↗
Tang Capital Management, LLC8.00%1.85M13GMay 15, 2025 ↗
Vanguard Capital Management5.65%1.21M13GApr 30, 2026 ↗

Insider tradesForm 4

Latest trades

No open-market trades in the last 12 months.

CongressHouse and Senate disclosures

Not reported.